Maria L. Randi

Padova, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 76 publications

A Toolkit for Healthcare Transition for Adolescents With Classical Myeloproliferative Neoplasms.

A Toolkit for Healthcare Transition for Adolescents With Classical Myeloproliferative Neoplasms.

Journal: Pediatric blood & cancer

Published: October 10, 2024

Impact of HFE mutations on thrombotic risk in patients with idiopathic erythrocytosis: A single-centre study.

Impact of HFE mutations on thrombotic risk in patients with idiopathic erythrocytosis: A single-centre study.

Journal: EJHaem

Published: September 11, 2024

Long-term pharmacodynamic and clinical effects of twice- versus once-daily low-dose aspirin in essential thrombocythemia: The ARES trial.

Long-term pharmacodynamic and clinical effects of twice- versus once-daily low-dose aspirin in essential thrombocythemia: The ARES trial.

Journal: American journal of hematology

Published: April 11, 2024

Coexistence of Multiple Gene Variants in Some Patients with Erythrocytoses.

Coexistence of Multiple Gene Variants in Some Patients with Erythrocytoses.

Journal: Mediterranean journal of hematology and infectious diseases

Published: November 03, 2023

Hematologic Neoplasms Associated with Down Syndrome: Cellular and Molecular Heterogeneity of the Diseases.

Hematologic Neoplasms Associated with Down Syndrome: Cellular and Molecular Heterogeneity of the Diseases.

Journal: International journal of molecular sciences

Published: September 22, 2023

TFR2 gene alterations in idiopathic erythrocytosis reinforce a possible relation between erythrocytosis and iron metabolism.

TFR2 gene alterations in idiopathic erythrocytosis reinforce a possible relation between erythrocytosis and iron metabolism.

Journal: Genes & diseases

Published: September 06, 2023

Acute myeloid leukemia: from NGS, through scRNA-seq, to CAR-T. dissect cancer heterogeneity and tailor the treatment.

Acute myeloid leukemia: from NGS, through scRNA-seq, to CAR-T. dissect cancer heterogeneity and tailor the treatment.

Journal: Journal of experimental & clinical cancer research : CR

Published: June 19, 2023

Survival expectation after thrombosis and overt-myelofibrosis in essential thrombocythemia and prefibrotic myelofibrosis: a multistate model approach.

Survival expectation after thrombosis and overt-myelofibrosis in essential thrombocythemia and prefibrotic myelofibrosis: a multistate model approach.

Journal: Blood cancer journal

Published: May 18, 2023

Characterization of genetic variants in the EGLN1/PHD2 gene identified in a European collection of patients with erythrocytosis.

Characterization of genetic variants in the EGLN1/PHD2 gene identified in a European collection of patients with erythrocytosis.

Journal: Haematologica

Published: February 10, 2023

Targeted NGS analysis reveals a complex genetic background of idiopathic erythrocytosis in a large Venetian family.

Targeted NGS analysis reveals a complex genetic background of idiopathic erythrocytosis in a large Venetian family.

Journal: Genes & diseases

Published: November 25, 2022

Assessment of the efficacy and tolerability of ruxolitinib for the treatment of myelofibrosis patients in a real-life setting: An Italian MYNERVA Project.

Assessment of the efficacy and tolerability of ruxolitinib for the treatment of myelofibrosis patients in a real-life setting: An Italian MYNERVA Project.

Journal: Cancer medicine

Published: October 17, 2022

Appropriateness of packed red blood cells transfusions in chronic anemic patients in the emergency department: the TRANSFUS-ED retrospective analysis.

Appropriateness of packed red blood cells transfusions in chronic anemic patients in the emergency department: the TRANSFUS-ED retrospective analysis.

Journal: Internal and emergency medicine

Published: February 05, 2022

Showing 1-12 of 76

Last Updated: 09/26/2026